$DHAI
DIH HOLDING US, INC. Stock $dhai

$dhai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224017073 Filed on April 29, 2024

Income Statement

Concept	2024 Q2	2023
Revenue	$16.19M	$54.06M
YoY Change
Cost Of Revenue	$7.521M	$23.47M
YoY Change	-1.66%
Gross Profit	$8.666M	$30.59M
YoY Change	60.57%
Gross Profit Margin	53.54%	56.58%
Selling, General & Admin	$8.676M	$22.96M
YoY Change	48.64%
% of Gross Profit	100.12%	75.06%
Research & Development	$1.644M	$6.919M
YoY Change	14.33%
% of Gross Profit	18.97%	22.62%
Depreciation & Amortization	$91.00K	$66.00K
YoY Change	15.19%
% of Gross Profit	1.05%	0.22%
Operating Expenses	$10.32M	$29.88M
YoY Change	1132.15%	-459.54%
Operating Profit	-$1.654M	-$3.528M
YoY Change	97.48%	106.88%
Interest Expense	$135.0K	$277.0K
YoY Change	-80.64%	-96.56%
% of Operating Profit
Other Income/Expense, Net	$1.763M	$4.168M
YoY Change	78.37%	-19.71%
Pretax Income	$109.0K	$1.004M
YoY Change	-27.74%	-84.8%
Income Tax	$723.0K	$2.018M
% Of Pretax Income	663.3%	201.0%
Net Earnings	-$614.0K	$640.2K
YoY Change	-507.04%	-90.31%
Net Earnings / Revenue	-3.79%	1.18%
Basic Earnings Per Share	-$0.02	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.04
COMMON SHARES
Basic Shares Outstanding	40.54M shares	25.00M
Diluted Shares Outstanding	34.54M	25.00M

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments			$5.560M
YoY Change			2809.47%
Cash & Equivalents	$2.749M	$12.36K	$5.560M
Short-Term Investments
Other Short-Term Assets	$6.194M		$3.662M
YoY Change	7221.51%		1186.72%
Inventory	$9.014M		$6.121M
Prepaid Expenses
Receivables	$5.690M		$6.079M
Other Receivables	$5.728M		$9.363M
Total Short-Term Assets	$29.38M	$12.36K	$30.79M
YoY Change	32254.88%	-97.4%	6371.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$664.0K		$4.026M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$933.0K		$40.00K
YoY Change
Total Long-Term Assets	$8.834M	$58.65M	$6.649M
YoY Change	-85.33%	-71.65%	-96.79%
TOTAL ASSETS
Total Short-Term Assets	$29.38M	$12.36K	$30.79M
Total Long-Term Assets	$8.834M	$58.65M	$6.649M
Total Assets	$38.21M	$58.66M	$37.43M
YoY Change	-36.62%	-71.71%	-81.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.368M	$2.349M	$3.200M
YoY Change	1135.45%	506.69%	726.53%
Accrued Expenses		$167.1K	$8.756M
YoY Change		234.1%	17412.0%
Deferred Revenue	$6.350M
YoY Change
Short-Term Debt			$12.98M
YoY Change
Long-Term Debt Due			$1.514M
YoY Change
Total Short-Term Liabilities	$48.24M	$4.618M	$58.61M
YoY Change	1447.9%	956.38%	13306.53%
LONG-TERM LIABILITIES
Long-Term Debt			$489.0K
YoY Change
Other Long-Term Liabilities	$4.304M		$7.000M
YoY Change	-42.2%		-8.61%
Total Long-Term Liabilities	$4.304M	$7.340M	$7.489M
YoY Change	-42.2%	-4.17%	-2.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.24M	$4.618M	$58.61M
Total Long-Term Liabilities	$4.304M	$7.340M	$7.489M
Total Liabilities	$72.20M	$11.96M	$66.49M
YoY Change	583.54%	47.69%	721.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$35.83M	-$11.95M
YoY Change	242.08%	56.75%
Common Stock	$3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$34.00M	-$11.95M	-$29.05M
YoY Change
Total Liabilities & Shareholders Equity	$38.21M	$58.66M	$37.43M
YoY Change	-36.62%	-71.71%	-81.95%

Cashflow Statement

Concept	2024 Q2	2023
OPERATING ACTIVITIES
Net Income	-$614.0K	$640.2K
YoY Change	-507.04%	-90.31%
Depreciation, Depletion And Amortization	$91.00K	$66.00K
YoY Change	15.19%
Cash From Operating Activities	-$2.010M	-$694.2K
YoY Change	798.81%	-36.66%
INVESTING ACTIVITIES
Capital Expenditures	$235.0K	$145.0K
YoY Change	1466.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$235.0K	$151.7M
YoY Change	-41.98%	-174.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$153.2M
YoY Change		-24.16%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.774M	-$151.2M
YoY Change	183.84%	-173.67%
NET CHANGE
Cash From Operating Activities	-2.010M	-$694.2K
Cash From Investing Activities	-235.0K	$151.7M
Cash From Financing Activities	1.774M	-$151.2M
Net Change In Cash	-476.0K	-$178.7K
YoY Change	13012.95%	-242.17%
FREE CASH FLOW
Cash From Operating Activities	-$2.010M	-$694.2K
Capital Expenditures	$235.0K	$145.0K
Free Cash Flow	-$2.245M	-$839.2K
YoY Change	840.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001883788
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023	DHAI	Gains Losses On Extinguishment Of Over Allotment Liability GainsLossesOnExtinguishmentOfOverAllotmentLiability		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	DHAI	Allocation Of Deferred Offering Costs For Warrant Liability AllocationOfDeferredOfferingCostsForWarrantLiability		usd
CY2023	DHAI	Gains Losses On Extinguishment Of Over Allotment Liability GainsLossesOnExtinguishmentOfOverAllotmentLiability		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments		usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	DHAI	Initial Measurement Of Classa Ordinary Shares Subject To Possible Redemption InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption		usd
CY2023	DHAI	Initial Measurement Of Public Warrants And Private Placement Warrants InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants		usd
CY2023	DHAI	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2023	DHAI	Forfeiture Of Representative Shares ForfeitureOfRepresentativeShares		usd
CY2023	DHAI	Stock Issued During Period Representative Shares Issued Value Class A StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA		usd
CY2023	DHAI	Deferred Offering Costs Incurred Included In Accrued Offering Costs DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41250
CY2023	dei	Entity Registrant Name EntityRegistrantName	DIH HOLDING US, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1624542
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 Accord Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite D-1
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Norwell
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02061
CY2023	dei	City Area Code CityAreaCode	(877)
CY2023	dei	Local Phone Number LocalPhoneNumber	944-2000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	63434566	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40544935	shares
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q4	us-gaap	Cash Cash	12355	usd
CY2022Q4	us-gaap	Cash Cash	191103	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	284597	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	12355	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	475700	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	58648639	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	206879903	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	58648639	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	206879903	usd
CY2023Q4	us-gaap	Assets Assets	58660994	usd
CY2022Q4	us-gaap	Assets Assets	207355603	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2348846	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30132	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	167050	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	357026	usd
CY2023Q4	DHAI	Accrued Offering Costs AccruedOfferingCosts	50000	usd
CY2022Q4	DHAI	Accrued Offering Costs AccruedOfferingCosts	50000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4618058	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	437158	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	270020	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	589420	usd
CY2023Q4	DHAI	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	7070000	usd
CY2022Q4	DHAI	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	7070000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7340020	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7659420	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11958078	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8096578	usd
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.05
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.24
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	58648639	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	206879903	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11946258	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7621413	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11945723	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58660994	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	207355603	usd
CY2023	DHAI	Formation And Operating Costs FormationAndOperatingCosts	3527996	usd
CY2022	DHAI	Formation And Operating Costs FormationAndOperatingCosts	1705315	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3527996	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1705315	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-319400	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5191127	usd
CY2022	DHAI	Gains Losses On Extinguishment Of Over Allotment Liability GainsLossesOnExtinguishmentOfOverAllotmentLiability	258440	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	364786	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	3484006	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2859903	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4168192	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8309470	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	640196	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6604155	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2023	DHAI	Remeasurement Of Redemption Value RemeasurementOfRedemptionValue	-4965041	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	640196	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11945723	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15037	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15037	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-32866490	usd
CY2022	DHAI	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022	DHAI	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6604155	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	640196	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6604155	usd
CY2023	DHAI	Investment Income Dividends InvestmentIncomeDividends	3484006	usd
CY2022	DHAI	Investment Income Dividends InvestmentIncomeDividends	2859903	usd
CY2022	DHAI	Allocation Of Deferred Offering Costs For Warrant Liability AllocationOfDeferredOfferingCostsForWarrantLiability	516746	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-319400	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5191127	usd
CY2022	DHAI	Gains Losses On Extinguishment Of Over Allotment Liability GainsLossesOnExtinguishmentOfOverAllotmentLiability	258440	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	364786	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	55662	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-284597	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	284597	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2493524	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	377211	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-694213	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1095955	usd
CY2022	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	204020000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1485000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	153200270	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	151715270	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204020000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	202000000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2525000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6470000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1996500	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	242801	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	460514	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153196305	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-151199805	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	205241685	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-178748	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	125730	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191103	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65373	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12355	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191103	usd
CY2022	DHAI	Initial Measurement Of Classa Ordinary Shares Subject To Possible Redemption InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption	174013413	usd
CY2022	DHAI	Initial Measurement Of Public Warrants And Private Placement Warrants InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants	5780547	usd
CY2022	DHAI	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	7070000	usd
CY2023	DHAI	Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	4965041	usd
CY2022	DHAI	Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	32866490	usd
CY2022	DHAI	Forfeiture Of Representative Shares ForfeitureOfRepresentativeShares	-70	usd
CY2022	DHAI	Stock Issued During Period Representative Shares Issued Value Class A StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA	30	usd
CY2022	DHAI	Deferred Offering Costs Incurred Included In Accrued Offering Costs DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts	50000	usd
CY2022Q1	DHAI	Overallotment Option Liability OverallotmentOptionLiability	258440	usd
CY2022Q1	DHAI	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022Q1	DHAI	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2022Q1	us-gaap	Cash Cash	1468333	usd
CY2023Q3	us-gaap	Subsequent Event Description SubsequentEventDescription	the Company held an extraordinary general meeting of shareholders (the “July Extraordinary General Meeting”), to, among other things, approve (i) a special resolution to amend the amended and restated articles of association of the Company (the “Articles”) giving the Company the right to further extend the Business Combination Period six (6) times for an additional one (1) month each time, from August 9, 2023 to February 7, 2024 (the “Second Extension Amendment”) and (ii) the proposal to approve the Second Trust Amendment (as defined below). All proposals at the July Extraordinary General Meeting were approved by the shareholders of the Company. As such, the Company and Transfer Agent entered into Amendment No. 2 to the Investment Management Trust Agreement, to allow ATAK to extend the Business Combination Period six (6) times for an additional one (1) month each time from August 9, 2023 to February 9, 2024 by depositing into the Trust Account for each one-month extension the lesser of: (x) $135,000 or (y) $0.045 per share multiplied by the number of public shares then outstanding (the “Second Trust Amendment”). In addition, on July 27, 2023, the Company adopted the Second Extension Amendment, amending the Company’s Articles. As of December 31, 2023, the Company exercised eleven of the one-month extensions, depositing a total of $1,485,000 into the Trust Account to fund the extensions
CY2023Q4	us-gaap	Cash Cash	12355	usd
CY2022Q4	us-gaap	Cash Cash	191103	usd
CY2023Q4	DHAI	Net Working Capital Surplus Deficit NetWorkingCapitalSurplusDeficit	-4605703	usd
CY2022Q4	DHAI	Net Working Capital Surplus Deficit NetWorkingCapitalSurplusDeficit	38542	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zyRyhyUtWjHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zjXI8jaQwlO4">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	DHAI	Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated	1	pure
CY2022Q1	DHAI	Overallotment Option Liability OverallotmentOptionLiability	258440	usd
CY2022Q1	DHAI	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022Q1	DHAI	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	14529877	shares
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	149322133	usd
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	3874172	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zuQ6JJegatSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_ztxOF9F0hNJ7">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zc7dtAgJPBM5" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	26670000	shares
CY2023	DHAI	Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo	P30D
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	270020	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	589420	usd

Files In Submission

Name	View Source	Status
0001493152-24-017073-index-headers.html	Edgar Link	pending
0001493152-24-017073-index.html	Edgar Link	pending
0001493152-24-017073.txt	Edgar Link	pending
0001493152-24-017073-xbrl.zip	Edgar Link	pending
dhai-20231231.xsd	Edgar Link	pending
dhai-20231231_cal.xml	Edgar Link	unprocessable
dhai-20231231_def.xml	Edgar Link	unprocessable
dhai-20231231_lab.xml	Edgar Link	unprocessable
ex14.htm	Edgar Link	pending
ex14_001.jpg	Edgar Link	pending
ex14_002.jpg	Edgar Link	pending
ex14_003.jpg	Edgar Link	pending
ex14_004.jpg	Edgar Link	pending
ex14_005.jpg	Edgar Link	pending
ex14_006.jpg	Edgar Link	pending
ex14_007.jpg	Edgar Link	pending
ex14_008.jpg	Edgar Link	pending
ex14_009.jpg	Edgar Link	pending
ex14_010.jpg	Edgar Link	pending
ex14_011.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
ex97-2.htm	Edgar Link	pending
ex97-3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dhai-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DHAI
DIH HOLDING US, INC. Stock $dhai

2024 Q2 Form 10-K Financial Statement

#000149315224017073 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHAI DIH HOLDING US, INC. Stock $dhai

2024 Q2 Form 10-K Financial Statement

#000149315224017073 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHAI
DIH HOLDING US, INC. Stock $dhai